Insider · CIK 0001827690
Robin Harper Cowie
Files at BDSX (BIODESIX INC). First filing Nov 13, 2024, latest Feb 23, 2026.
Robin Harper Cowie files SEC Form 4 as CFO at BDSX (BIODESIX INC). Since Nov 13, 2024, Robin Harper Cowie has reported 0 open-market buys worth $0 and 8 open-market sells worth $44k, the latest filed on Feb 23, 2026.
A track record needs three past buys with six months of prices behind them; Robin Harper Cowie has 0, so none is measured yet.
The newest scored trade: sold $6,835 of BDSX on Feb 23, 2026, filed Feb 23, 2026, scored 22 (weak). In the last 12 months: 0 buys worth $0 and 4 sells worth $19k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BDSX: BIODESIX INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 22Weak | BIODESIX INC | $6,835 535 shares | -3% | +190% from low-27% from high | |
| 22Weak | BIODESIX INC | $9,489 941 shares | -6% | +136% from low-47% from high | |
| 22Weak | BIODESIX INC | $2,428 298 shares | -2% | +79% from low-66% from high | |
| 22Weak | BIODESIX INC | $381 50 shares | -0% | +71% from low-76% from high | |
| 22Weak | BIODESIX INC | $411 988 shares | -0% | +75% from low-79% from high | |
| 22Weak | BIODESIX INC | $353 992 shares | -0% | +3% from low-80% from high | |
| 22Weak | BIODESIX INC | $23k 24,664 shares | -9% | - | |
| 22Weak | BIODESIX INC | $1,355 971 shares | -0% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 11, 2025 | BDSX BIODESIX INC | 24,664 0.02% of outstanding | $23k | Feb 11, 2025 | $660 |
Transactions
Every row this insider has filed, 33 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 20, 2026 | BDSX BIODESIX INC | MOption exercise Common Stock | +1,469 | - | - | 16,766 | Feb 23, 2026 |
| Feb 23, 2026 | BDSX BIODESIX INC | SOpen-market sale Common Stock | -535 | $12.78 | $6,835 | 16,231 | Feb 23, 2026 |
| Feb 20, 2026 | BDSX BIODESIX INC | MOption exercise Restricted Stock Unitsderivative | -1,469 | $0.00 | $0 | 4,406 | Feb 23, 2026 |
| Feb 9, 2026 | BDSX BIODESIX INC | MOption exercise Common Stock | +2,584 | - | - | 16,238 | Feb 11, 2026 |
| Feb 10, 2026 | BDSX BIODESIX INC | SOpen-market sale Common Stock | -941 | $10.08 | $9,489 | 15,297 | Feb 11, 2026 |
| Feb 9, 2026 | BDSX BIODESIX INC | MOption exercise Restricted Stock Unitsderivative | -157 | $0.00 | $0 | 0 | Feb 11, 2026 |
| Feb 9, 2026 | BDSX BIODESIX INC | MOption exercise Restricted Stock Unitsderivative | -2,427 | $0.00 | $0 | 2,426 | Feb 11, 2026 |
| Jan 15, 2026 | BDSX BIODESIX INC | MOption exercise Common Stock | +805 | - | - | 13,952 | Jan 20, 2026 |
| Jan 16, 2026 | BDSX BIODESIX INC | SOpen-market sale Common Stock | -298 | $8.15 | $2,428 | 13,654 | Jan 20, 2026 |
| Jan 15, 2026 | BDSX BIODESIX INC | MOption exercise Restricted Stock Unitsderivative | -805 | $0.00 | $0 | 1,609 | Jan 20, 2026 |
| Jan 2, 2026 | BDSX BIODESIX INC | AGrant or award Stock Options (Right to Buy)derivative | +29,000 | $0.00 | $0 | 29,000 | Jan 6, 2026 |
| Nov 10, 2025 | BDSX BIODESIX INC | MOption exercise Common Stock | +158 | - | - | 13,197 | Nov 13, 2025 |
| Nov 10, 2025 | BDSX BIODESIX INC | SOpen-market sale Common Stock | -50 | $7.62 | $381 | 13,147 | Nov 13, 2025 |
| Nov 10, 2025 | BDSX BIODESIX INC | MOption exercise Restricted Stock Unitsderivative | -158 | $0.00 | $0 | 157 | Nov 13, 2025 |
| Aug 12, 2025 | BDSX BIODESIX INC | MOption exercise Common Stock | +3,157 | - | - | 251,782 | Aug 14, 2025 |
| Aug 13, 2025 | BDSX BIODESIX INC | SOpen-market sale Common Stock | -988 | $0.42 | $411 | 250,794 | Aug 14, 2025 |
| Aug 12, 2025 | BDSX BIODESIX INC | MOption exercise Restricted Stock Unitsderivative | -3,157 | $0.00 | $0 | 6,313 | Aug 14, 2025 |
| May 9, 2025 | BDSX BIODESIX INC | MOption exercise Common Stock | +3,157 | - | - | 249,617 | May 13, 2025 |
| May 12, 2025 | BDSX BIODESIX INC | SOpen-market sale Common Stock | -496 | $0.36 | $178 | 249,121 | May 13, 2025 |
| May 13, 2025 | BDSX BIODESIX INC | SOpen-market sale Common Stock | -496 | $0.35 | $175 | 248,625 | May 13, 2025 |
| May 9, 2025 | BDSX BIODESIX INC | MOption exercise Restricted Stock Unitsderivative | -3,157 | $0.00 | $0 | 9,470 | May 13, 2025 |
| Feb 20, 2025 | BDSX BIODESIX INC | AGrant or award Restricted Stock Unitsderivative | +117,500 | $0.00 | $0 | 117,500 | Feb 26, 2025 |
| Feb 20, 2025 | BDSX BIODESIX INC | AGrant or award Stock Options (Right to buy)derivative | +235,000 | $0.00 | $0 | 235,000 | Feb 26, 2025 |
| Feb 20, 2025 | BDSX BIODESIX INC | AGrant or award Stock Options (Right to buy)derivative | +73,398 | $0.00 | $0 | 73,398 | Feb 26, 2025 |
| Feb 10, 2025 | BDSX BIODESIX INC | MOption exercise Common Stock | +67,788 | - | - | 271,124 | Feb 12, 2025 |
| Feb 11, 2025 | BDSX BIODESIX INC | SOpen-market sale Common Stock | -24,664 | $0.92 | $23k | 246,460 | Feb 12, 2025 |
| Feb 10, 2025 | BDSX BIODESIX INC | MOption exercise Restricted Stock Unitsderivative | -3,157 | $0.00 | $0 | 12,627 | Feb 12, 2025 |
| Feb 10, 2025 | BDSX BIODESIX INC | MOption exercise Restricted Stock Unitsderivative | -48,536 | $0.00 | $0 | 97,070 | Feb 12, 2025 |
| Feb 10, 2025 | BDSX BIODESIX INC | MOption exercise Restricted Stock Unitsderivative | -16,095 | $0.00 | $0 | 48,286 | Feb 12, 2025 |
| Nov 8, 2024 | BDSX BIODESIX INC | MOption exercise Common Stock | +3,156 | - | - | 204,307 | Nov 13, 2024 |
| Nov 11, 2024 | BDSX BIODESIX INC | SOpen-market sale Common Stock | -500 | $1.39 | $695 | 203,807 | Nov 13, 2024 |
| Nov 12, 2024 | BDSX BIODESIX INC | SOpen-market sale Common Stock | -471 | $1.40 | $660 | 203,336 | Nov 13, 2024 |
| Nov 8, 2024 | BDSX BIODESIX INC | MOption exercise Restricted Stock Unitsderivative | -3,156 | $0.00 | $0 | 15,784 | Nov 13, 2024 |
Questions about Robin Harper Cowie
Answered from the filings on this page, as of the latest one.
Is Robin Harper Cowie buying or selling?
In the last 12 months Robin Harper Cowie reported 0 open-market buys worth $0 and 4 open-market sells worth $19k on SEC Form 4; the latest was sold $6,835 of BDSX on Feb 23, 2026. Grants, option exercises and tax withholding are not counted.
How did Robin Harper Cowie's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Robin Harper Cowie has 0.
Where does Robin Harper Cowie file Form 4?
Robin Harper Cowie has filed Form 4 at BDSX (BIODESIX INC) as CFO, Sec'y & Treasurer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.